(19)
(11) EP 4 680 243 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24720357.3

(22) Date of filing: 15.03.2024
(51) International Patent Classification (IPC): 
A61K 31/513(2006.01)
A61K 31/711(2006.01)
A61K 31/7088(2006.01)
A61P 27/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 27/02; A61K 31/7088; A61K 31/513; A61K 31/675; A61K 31/683; A61K 31/5377; A61K 31/47; A61K 31/155; A61K 31/635; A61K 31/7105; A61K 45/06; C12N 9/22; C12N 2310/20; C12N 15/1132; C12N 2310/14; A61K 38/1891; A61K 35/761; A61K 35/30
 
C-Sets:
  1. A61K 31/47, A61K 2300/00;
  2. A61K 31/155, A61K 2300/00;
  3. A61K 31/635, A61K 2300/00;
  4. A61K 31/7105, A61K 2300/00;
  5. A61K 31/7088, A61K 2300/00;
  6. A61K 35/761, A61K 2300/00;
  7. A61K 31/675, A61K 2300/00;
  8. A61K 38/1891, A61K 2300/00;
  9. A61K 31/683, A61K 2300/00;
  10. C12N 2310/14, C12N 2310/531;
  11. A61K 31/513, A61K 2300/00;
  12. A61K 31/5377, A61K 2300/00;

(86) International application number:
PCT/US2024/020294
(87) International publication number:
WO 2024/196814 (26.09.2024 Gazette 2024/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 17.03.2023 US 202363453006 P

(71) Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services
Bethesda, Maryland 20892-7788 (US)

(72) Inventors:
  • BHARTI, Kapil
    Bethesda, Maryland 20892 (US)
  • ZHANG, Congxiao
    Bethesda, Maryland 20892 (US)
  • FAUSEY, Andrew Jacob
    Minster, Ohio 45865 (US)
  • SHARMA, Ruchi
    Bethesda, Maryland 20892 (US)

(74) Representative: Symbiosis IP Limited 
Innovation Centre Innovation Way
Heslington, York YO10 5DG
Heslington, York YO10 5DG (GB)

   


(54) METHODS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION